Render Target: STATIC
Render Timestamp: 2024-11-22T10:52:21.537Z
Commit: 5c4accf06eb7154018ba3f54329c7590f97f534a
XML generation date: 2024-04-24 09:10:49.078
Product last modified at: 2024-10-22T19:00:09.481Z
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

Beta-d-N4-Hydroxycytidine #81178

    Product Information

    Product Usage Information

    Beta-d-N4-Hydroxycytidine is supplied as a lyophilized powder. For a 15 mM stock, reconstitute 5 mg of powder in 1.28 ml of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Storage

    Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 259.2 g/mol
    Purity >98%
    Molecular Formula C9H13N3O6
    CAS 3258-02-4
    Solubility Soluble in DMSO at 25 mg/ml or water at 15 mg/ml with slight warming.

    Background

    Beta-d-N4-Hydroxycytidine, also known as EIDD-1931, is a nucleic acid base analog and a specific AT to GC mutagen formed by the treatment of nucleoside cytidine with hydroxylamine (1). Beta-d-N4-Hydroxycytidine acts as a competitive substrate for viral encoded RNA polymerase and has demonstrated broad in vitro antiviral activity, including Chikungunya virus, Ebola, and Hepatitis C (2-4). Beta-d-N4-Hydroxycytidine demonstrated an IC50 value of 0.1 µM and an IC90 value of 6 µM in SARS-CoV infected Vero cells (5,6).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.